As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked doctors specialize in the development of these studies — specifically phase 1 and 2 trials. A pilot clinical trial about stage 2-4 HIV-associated Hodgkin Lymphoma will be led by Stefan Barta, MD, a medical oncologist at Fox Chase who specializes in Hematology.
In 2012, Fox Chase nurse Pam Jakubek became a patient herself and gained a greater appreciation for the notion that cancer doesn’t take any days off. Her situation on Christmas Eve activated the hospital’s Rapid Response team, bringing in a full staff on a normally slow day. She was deeply moved by the response of the entire Fox Chase community.
Shelukar worked throughout the year, developing prototypes, and getting feedback from Allison Aggon, DO, a surgical oncologist specializing in breast cancer, as well as our nurse navigators. After months of trial and error, Shelukar had her final product in June 2016. It’s a soft cloth-covered cushion that wraps around the seatbelt and stays in place with a Velcro strip fastener. She named it the Soothing Sleeve.
The colorful painting of three large sunflowers stretches across a wall between the Hospital and Center buildings, and extends out into a peaceful corner of the courtyard. Artist Loraine Dunn painted the beautiful mural over the course of two weekends with the support of the Friends of the Hospital of Fox Chase Cancer Center.
"When I was young I never dreamed of being a scientist until my father died of liver cancer when I was twelve years old. After his death, I chose to become a pharmacist to develop new, effective drugs to fight cancer and I initially pursued a bachelor’s degree in the field of biopharmaceutics at the Chinese Pharmacology University. During my last semester, however, my focus changed following an experience in Dr. Luo Lu’s lab at Shanghai Institute of Health Sciences."
November was National Lung Cancer Awareness Month, and Fox Chase Cancer Center started off the month with Together Facing Lung Cancer, an event that united lung cancer survivors, caregivers, and health care professionals for an evening of education, discussion, and hope.
A research team led by Alexei Tulin, PhD, associate professor at Fox Chase Cancer Center, has identified a new group of chemicals that are effective at eliminating cancer in living tissue. Effective in a laboratory setting against drug-resistant PARP-1 tumors, these treatments had minimal toxicity and fewer side effects than conventional treatments for breast, kidney, and prostate cancer.